~~<i id='A1B03476E0'><strike id='A1B03476E0'><tt id='A1B03476E0'><pre id='A1B03476E0'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

explore

author：explore 2025-09-30 22:10:38 - browse：351

The Food and Drug Administration on Thursday approved a gene therapy to treat people with hemophilia A, an inherited and rare bleeding disorder.

The treatment, called Roctavian, is made by BioMarin Pharmaceutical. It was first approved in Europe in August 2022.

Roctavian is a one-time therapy that, in clinical trials, dramatically reduced bleeding episodes and helped patients live without the blood transfusions used to treat the disease. The FDA first rejected Roctavian in 2020, asking BioMarin to amass more data on its safety and long-term durability, and then delayed its decision again to account for additional evidence.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Moonlake's readout produced a cash windfall. Risks remain
Next article： High breast density mammograms need follow

focus

knowledge

explore

leisure time

entertainment

hotspot

MollyFergusonforSTATIn1906,Dr.AloisAlzheimerworkedwithapatientnamedAugustD.,awomanwithextremememoryl

WSS

Judge schedules Friday hearing on proposed protective order in Jan. 6 case

Dana Farber says 6 studies to be retracted and 31 corrected

Ohioans vote in high

Mass General, Mayo Clinic look to monetize custom

Wegovy cuts risk of cardiovascular events by 20%, study finds

Sage's campaign to raise awareness of postpartum depression hits a nerve

explore

explore

focus

What does generative AI mean for health care? We asked experts

Medicare bonuses could stop drug shortages under Senate plan

Supreme Court strikes down use of affirmative action

Inaction leaves children at risk from dangerous chemotherapy drug

Walensky prepares to leave CDC — and Congress — behind

There's an unseen cost to disruptive road

Anesthesiologist group: stop taking Ozempic before surgery

Update the Apgar Score to remove skin color

In Memoriam: Notable people who died in 2023

FTX founder Sam Bankman

knowledge

Germany receives 178 compensation applications from gay servicepeople over discrimination

Judge rejects Trump's counterclaim against E. Jean Carroll

More regulation could be coming for drug ads

Boston man files lawsuit seeking to bankrupt white supremacist group he says assaulted him

Maisha Meds is a PBM, but don't call it that

TikTok, Instagram influencers need more rules for drug ads

explore

leisure time

entertainment

hotspot